CRISPR-GPT for Agentic Automation of Gene-editing Experiments
Yuanhao Qu, Kaixuan Huang, Ming Yin, Kanghong Zhan, Dyllan Liu, Di Yin, Henry C. Cousins, William A. Johnson, Xiaotong Wang, Mihir Shah, Russ B. Altman, Denny Zhou, Mengdi Wang, Le Cong
TL;DR
CRISPR-GPT presents an AI-driven design agent that combines targeted domain knowledge with tool integration to automate CRISPR gene-editing design tasks, addressing the limitations of general LLMs in biology. The system uses a modular, state-machine workflow with four core components to manage 22 tasks across four meta-tasks, enabling end-to-end planning from CRISPR system selection to validation. Expert evaluation and a real-world A375 knockout demonstration show superior accuracy and completeness compared with general LLMs, while Safety and Ethics sections outline safeguards for heritable editing and data privacy. The work signals a path toward responsible, scalable, AI-assisted design of gene-editing workflows and hints at future integration with automated laboratory platforms.
Abstract
The introduction of genome engineering technology has transformed biomedical research, making it possible to make precise changes to genetic information. However, creating an efficient gene-editing system requires a deep understanding of CRISPR technology, and the complex experimental systems under investigation. While Large Language Models (LLMs) have shown promise in various tasks, they often lack specific knowledge and struggle to accurately solve biological design problems. In this work, we introduce CRISPR-GPT, an LLM agent augmented with domain knowledge and external tools to automate and enhance the design process of CRISPR-based gene-editing experiments. CRISPR-GPT leverages the reasoning ability of LLMs to facilitate the process of selecting CRISPR systems, designing guide RNAs, recommending cellular delivery methods, drafting protocols, and designing validation experiments to confirm editing outcomes. We showcase the potential of CRISPR-GPT for assisting non-expert researchers with gene-editing experiments from scratch and validate the agent's effectiveness in a real-world use case. Furthermore, we explore the ethical and regulatory considerations associated with automated gene-editing design, highlighting the need for responsible and transparent use of these tools. Our work aims to bridge the gap between beginner biological researchers and CRISPR genome engineering techniques, and demonstrate the potential of LLM agents in facilitating complex biological discovery tasks. The published version of this draft is available at https://www.nature.com/articles/s41551-025-01463-z.
